National HealthCare Corporation

Valuation Analysis

About the Company

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. It provides medical specialty units comprise memory care units and s

National HealthCare Corporation Stock at a Glance

National HealthCare Corporation (NHC) is currently trading at $197.72 with a market capitalization of $3.1B. The trailing P/E ratio stands at 25.12x, with a forward P/E of 459.81x. The 52-week range spans from $93.54 to $205.06; the current price is 3.6% below the yearly high. Year-over-year revenue growth stands at +2.2%. The net profit margin stands at 8.1%.

💰 Dividend

National HealthCare Corporation pays an annual dividend of $2.59 per share, representing a yield of 1.31%. The payout ratio stands at 32.53%.

National HealthCare Corporation: The Investment Case in Detail

National HealthCare Corporation (NHC) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

Revenue growth has slowed to just 2.2%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

Valuation in Context

With a PEG ratio of 0.82, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

What to Watch Next

• The share is trading at 93.4% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy National HealthCare Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.